Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health, and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test, which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor, Precise Liquid, SneakPeek and GeneSight, among others.
What is the share price of Myriad Genetics Inc. today?
Myriad Genetics Inc. (MYGN) share price as of April 3, 2026 is $4.75. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Myriad Genetics Inc.?
Yes, Indian Investors can invest in the Myriad Genetics Inc. (MYGN) Share by opening an international trading account with Angel One.
How can I purchase Myriad Genetics Inc. shares in India?
Purchasing Myriad Genetics Inc. (MYGN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Myriad Genetics Inc. (MYGN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Myriad Genetics Inc.?
Yes, you can purchase fractional shares of Myriad Genetics Inc. (MYGN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Myriad Genetics Inc.?
The market capitalization of Myriad Genetics Inc. on February 11, 2026, is $444.16 M.
In which sector Myriad Genetics Inc. belongs?
Myriad Genetics Inc. operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
What documents are required to invest in Myriad Genetics Inc. stocks?
In order to invest in Myriad Genetics Inc. (MYGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
